Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine

Published:2013-07-23 Issue:9 Volume:88 Page:780-783
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Cluzeau Thomas,Mounier Nicolas¹,Karsenti Jean-Michel¹,Richez Valentine¹,Legros Laurence,Gastaud Lauris²,Garnier Georges³,Re Daniel⁴,Montagne Nathalie⁵,Gutnecht Jean⁶,Gabriel Fuzibet Jean⁷,Auberger Patrick⁸,Raynaud Sophie⁹,Cassuto Jill-Patrice¹

Affiliation:

1. Service d'Hématologie clinique; CHU Nice; Nice; France

2. Service d'oncologie médicale; Centre Lacassagne; Nice; France

3. Service médecine interne; CHPG; Monaco; Monaco

4. Medecine 3; CH Antibes; Antibes; France

5. Service médecine interne; CH Cannes; Cannes; France

6. Service médecine interne; Centre hospitalier intercommunal de Fréjus-St Raphael; Fréjus; France

7. Service de médecine interne; CHU Nice; Nice; France

8. Centre Méditerranéen de médecine moléculaire; INSERM U1065; Nice; France

9. Laboratoire d'hématologie; CHU Nice; Nice; France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23509/fullpdf

Reference21 articles.

1. Myelodysplastic syndromes;Tefferi;New England J Med,2009

2. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman;Blood,2009

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes;Malcovati;J Clin Oncol,2007

5. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System;Kantarjian;Cancer,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine—A Retrospective Analysis;Cancers;2024-03-29

2. Clinical, immunophenotypic, and cytogenetic characteristics of high‐grade myelodysplastic syndromes with CD41 ‐positive progenitor cells;Cytometry Part B: Clinical Cytometry;2021-12-28

3. Predicting outcome in higher-risk myelodysplastic syndrome patients treated with azacitidine;Epigenomics;2021-07

4. Factors affecting response to 5-azacytidine and prognosis of myelodysplastic syndrome. Is long-term survival a realistic goal?;Leukemia Research;2021-04

5. Clinical significance of CD41‐positive blasts in association with a monosomal karyotype in patients with myelodysplastic syndrome treated with azacitidine;British Journal of Haematology;2020-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3